ABSTRACT
These multidisciplinary presentations provide information essential to devising effective drug protocols in cardiovascular drug development, facilitating the approval process.
Guides researchers and developers through the government drug approval process, facilitating development, minimizing costs, and harmonizing international standards employ
TABLE OF CONTENTS
part |2 pages
DEVELOPMENT OF CONGESTIVE HEART FAILURE THERAPY
part |2 pages
DEVELOPMENT OF ANTIHYPERTENSIVE THERAPY
part |2 pages
DEVELOPMENT OF ANTIARRHYTHMIC DRUG THERAPY
part |2 pages
DEVELOPMENT OF ANTILIPID AND ANTI-ISCHEMIC THERAPY
part |2 pages
CONCLUSION
